72.11.Z - Scientific research and development activities
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.74.Z - Retail sale of medical and orthopedic products
72.19.Z - Scientific research and development activities
86.10.Z - Hospital activities
86.21.Z - General medical practice
86.22.Z - Specialist medical practice
86.90.A - Healthcare
86.90.D - Healthcare
86.90.E - Healthcare
2017 | 2018 | 2019 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -18,1 | 28 | 15,9 | -43,1 |
EBITDA | -18 | 31,4 | 19,3 | -38,4 |
Short time liabilities | 58,2 | 64 | 64 | 0 |
Equity capital | -10,4 | 13,9 | 26,8 | 92,9 |
Operating profit (EBIT) | -18 | 31,4 | 19,3 | -38,4 |
Assets | 47,8 | 77,9 | 90,8 | 16,6 |
Net profit (loss) | -15,4 | 24,3 | 12,9 | -46,9 |
Cash | 44,7 | 75,5 | 89,3 | 18,3 |
Net income from sale | 0 | 408 | 549,3 | 34,6 |
Liabilities and provisions for liabilities | 58,2 | 64 | 64 | 0 |
Working assets | 45,1 | 75,5 | 89,4 | 18,5 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 148 | 175,1 | 48,2 | -126,9 |
Equity capital to total assets | -21,8 | 17,8 | 29,5 | 11,7 |
Gross profit margin | 6,9 | 2,9 | -4 | |
EBITDA Margin | 7,7 | 3,5 | -4,2 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 57 | 43 | -14 |
Current financial liquidity indicator | 0.7745526432991028 | 1.1793652772903442 | 1.3971803188323975 | 0,2 |
Net dept to EBITDA | -0.7182961702346802 | -0.47423723340034485 | -1.3059290647506714 | -0,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane